- Home
- ATYR vs EWCZ Comparison
ATYR vs EWCZ Comparison
Compare ATYR & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | EWCZ |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 166.5M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATYR | EWCZ |
|---|---|---|
| Price | $0.78 | $4.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $8.75 | $5.50 |
| AVG Volume (30 Days) | ★ 2.6M | 372.7K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.45 |
| EPS | N/A | ★ 0.26 |
| Revenue | $190,000.00 | ★ $211,264,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | $1.62 |
| P/E Ratio | ★ N/A | $15.62 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $2.72 |
| 52 Week High | $7.29 | $7.60 |
Technical Indicators
Market Signals| Indicator | ATYR | EWCZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 56.58 |
| Support Level | $0.70 | $3.87 |
| Resistance Level | $0.83 | $4.33 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 57.87 | 64.40 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.